ZA911925B - Novel pyrazole derivatives which are angiotensin ii receptor antagonists;their methods of preparation and pharmaceutical compositions in which they are present - Google Patents
Novel pyrazole derivatives which are angiotensin ii receptor antagonists;their methods of preparation and pharmaceutical compositions in which they are presentInfo
- Publication number
- ZA911925B ZA911925B ZA911925A ZA911925A ZA911925B ZA 911925 B ZA911925 B ZA 911925B ZA 911925 A ZA911925 A ZA 911925A ZA 911925 A ZA911925 A ZA 911925A ZA 911925 B ZA911925 B ZA 911925B
- Authority
- ZA
- South Africa
- Prior art keywords
- angiotensin
- preparation
- methods
- pharmaceutical compositions
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
- C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9003485A FR2659655B1 (fr) | 1990-03-19 | 1990-03-19 | Nouveaux derives d'oxypyrazole antagonistes des recepteurs a l'angiotensine ii ; leurs procedes de preparation, compositions pharmaceutiques les contenant. |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA911925B true ZA911925B (en) | 1992-03-25 |
Family
ID=9394876
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA911925A ZA911925B (en) | 1990-03-19 | 1991-03-15 | Novel pyrazole derivatives which are angiotensin ii receptor antagonists;their methods of preparation and pharmaceutical compositions in which they are present |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0449699A3 (xx) |
JP (1) | JPH04234851A (xx) |
KR (1) | KR910016708A (xx) |
AU (1) | AU7359191A (xx) |
CA (1) | CA2038428A1 (xx) |
FR (1) | FR2659655B1 (xx) |
IE (1) | IE910766A1 (xx) |
IL (1) | IL97576A0 (xx) |
NZ (1) | NZ237445A (xx) |
PT (1) | PT97056A (xx) |
ZA (1) | ZA911925B (xx) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05505822A (ja) * | 1990-03-30 | 1993-08-26 | メルク・エンド・カムパニー・インコーポレーテツド | ピラゾール類、イソキサゾール類及びイソチアゾール置換体 |
GB9110623D0 (en) * | 1991-05-16 | 1991-07-03 | Glaxo Group Ltd | Chemical compounds |
AP254A (en) * | 1991-09-05 | 1993-05-05 | Glaxo Group Ltd | C-Linked pyrazole derivatives. |
WO1993005025A1 (en) * | 1991-09-06 | 1993-03-18 | Glaxo Group Limited | C-linked pyrazole derivatives |
FR2685697B1 (fr) * | 1991-12-30 | 1994-02-04 | Synthelabo | Nouveaux derives de 2-(tetrazol-5-yl)-(1,1'-biphenyle), leur preparation et leur utilisation comme intermediaires de synthese. |
EP0550313A1 (fr) * | 1991-12-30 | 1993-07-07 | Synthelabo | Nouveaux dérivés de 2-(tétrazol-5-yl)-(1,1'-biphényle), leur préparation et leur utilisation comme intermédiaires de synthèse |
US5264451A (en) * | 1992-04-07 | 1993-11-23 | American Home Products Corporation | Process for treating hyperglycemia using trifluoromethyl substituted 3H-pyrazol-3-ones |
GB9218449D0 (en) | 1992-08-29 | 1992-10-14 | Boots Co Plc | Therapeutic agents |
TW348175B (en) * | 1993-01-06 | 1998-12-21 | Hoechst Ag | Process for the preparation of biphenyl derivatives |
US5262412A (en) * | 1993-03-10 | 1993-11-16 | Merck & Co., Inc. | Substituted pyrazoles, compositions and use |
US5338740A (en) * | 1993-07-13 | 1994-08-16 | Pfizer Inc. | Angiotensin II receptor antagonists |
FR2740135B1 (fr) * | 1995-10-20 | 1997-12-19 | Roussel Uclaf | Nouveaux derives de pyrazoles acides, leur procede de preparation, leur application a titre de medicaments, leur nouvelle utilisation et les compositions pharmaceutiques les renfermant |
AU751139B2 (en) * | 1997-10-13 | 2002-08-08 | Astellas Pharma Inc. | Amide derivative |
DE19830431A1 (de) | 1998-07-08 | 2000-01-13 | Hoechst Marion Roussel De Gmbh | Sulfonylamino-carbonsäure-N-arylamide als Guanylatcyclase-Aktivatoren |
SE9903028D0 (sv) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
AU2002225356B2 (en) | 2000-12-28 | 2008-03-06 | Kissei Pharmaceutical Co., Ltd. | Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
TW593329B (en) | 2001-02-26 | 2004-06-21 | Kissei Pharmaceutical | Glucopyranosyloxypyrazole derivatives and pharmaceutical uses thereof |
CA2438595C (en) * | 2001-02-27 | 2011-08-09 | Kissei Pharmaceutical Co., Ltd. | Glucopyranosyloxypyrazole derivatives and medicinal use thereof |
KR100459938B1 (ko) * | 2001-10-16 | 2004-12-03 | 한국화학연구원 | 농·의약 합성중간체로 유용한 불소 치환기 함유헤테로고리 화합물 및 이의 제조방법 |
DK2170930T3 (da) | 2007-06-04 | 2012-11-05 | Synergy Pharmaceuticals Inc | Agonister af guanylatcyclase, anvendelige til behandlingen af gastrointestinale sygdomme, inflammation, cancer og andre sygdomme |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
JP2011522828A (ja) | 2008-06-04 | 2011-08-04 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト |
ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
WO2013155422A1 (en) * | 2012-04-12 | 2013-10-17 | Ironwood Pharmaceuticals, Inc. | Methods of treating alopecia and acne |
US9708367B2 (en) | 2013-03-15 | 2017-07-18 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
AU2014235209B2 (en) | 2013-03-15 | 2018-06-14 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists combined with other drugs |
KR102272746B1 (ko) | 2013-06-05 | 2021-07-08 | 보슈 헬스 아일랜드 리미티드 | 구아닐레이트 사이클라제 c의 초순수 작용제, 및 이의 제조 및 사용 방법 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2319281A1 (de) * | 1973-04-17 | 1974-11-07 | Bayer Ag | Diuretisches und antihypertensives mittel |
DE2347015C2 (de) * | 1973-09-14 | 1985-12-12 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue Pyrazolyloxyessigsäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende Mittel |
DE2828529A1 (de) * | 1978-06-29 | 1980-01-17 | Kali Chemie Pharma Gmbh | Neue 5-phenylpyrazol-derivate, verfahren zu deren herstellung und arzneimittel |
CA1211111A (en) * | 1982-02-15 | 1986-09-09 | Isao Yanagisawa | Process for preparing novel pyrimidone compounds |
US5015651A (en) * | 1988-01-07 | 1991-05-14 | E. I. Du Pont De Nemours And Company | Treatment of hypertension with 1,2,4-angiotensin II antagonists |
GB9005354D0 (en) * | 1990-03-09 | 1990-05-02 | Glaxo Group Ltd | Chemical compounds |
-
1990
- 1990-03-19 FR FR9003485A patent/FR2659655B1/fr not_active Expired - Fee Related
-
1991
- 1991-03-07 IE IE076691A patent/IE910766A1/en unknown
- 1991-03-15 NZ NZ237445A patent/NZ237445A/en unknown
- 1991-03-15 ZA ZA911925A patent/ZA911925B/xx unknown
- 1991-03-15 PT PT97056A patent/PT97056A/pt not_active Application Discontinuation
- 1991-03-18 EP EP19910400717 patent/EP0449699A3/fr not_active Withdrawn
- 1991-03-18 AU AU73591/91A patent/AU7359191A/en not_active Abandoned
- 1991-03-18 IL IL97576A patent/IL97576A0/xx unknown
- 1991-03-18 CA CA002038428A patent/CA2038428A1/en not_active Abandoned
- 1991-03-19 KR KR1019910004356A patent/KR910016708A/ko not_active Application Discontinuation
- 1991-03-19 JP JP3078251A patent/JPH04234851A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
PT97056A (pt) | 1991-10-31 |
KR910016708A (ko) | 1991-11-05 |
AU7359191A (en) | 1991-09-19 |
EP0449699A2 (fr) | 1991-10-02 |
IE910766A1 (en) | 1991-09-25 |
EP0449699A3 (en) | 1993-04-07 |
CA2038428A1 (en) | 1991-09-20 |
NZ237445A (en) | 1993-04-28 |
FR2659655A1 (fr) | 1991-09-20 |
IL97576A0 (en) | 1992-06-21 |
FR2659655B1 (fr) | 1992-07-24 |
JPH04234851A (ja) | 1992-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA911925B (en) | Novel pyrazole derivatives which are angiotensin ii receptor antagonists;their methods of preparation and pharmaceutical compositions in which they are present | |
IL98674A0 (en) | Novel pyrimidine derivatives which are angiotensin ii receptor antagonists,their methods of preparation and pharmaceutical compositions in which they are present | |
IL99246A0 (en) | Angiotensin ii receptor antagonists and pharmaceutical compositions containing them | |
HUP9902121A3 (en) | Indole derivatives as antagonists of gonadotropin releasing hormone and pharmaceutical compositions containing them | |
ZA9610299B (en) | Pyrazole derivatives process for their preparation and pharmaceutical compositions in which they are present | |
IL116957A0 (en) | Substituted heterocyclic compounds their preparation and pharmaceutical compositions containing them | |
HK1012246A1 (en) | Pharmaceutical compositions of an imidazolyl-akenoic acid salt and their use as angiotensin ii antagonists | |
HUP9901296A3 (en) | Substituted piperidine derivatives as nmda receptor antagonists and pharmaceutical compositions containing them | |
IL114492A0 (en) | Benzimidazole derivatives their preparation and pharmaceutical compositions containing them | |
HK1002030A1 (en) | Heterocyclic derivatives of acylaminothiazole their preparation and pharmaceutical compositions containing them | |
NZ235726A (en) | Substituted pyrimidine derivatives; their preparation and pharmaceutical compositions | |
HUP0004150A3 (en) | Indazole derivatives as tyrosine kinase receptor antagonists and pharmaceutical compositions containing them | |
NZ238545A (en) | Dialkoxy-pyridinyl-benzimidazole derivatives; preparation and pharmaceutical compositions thereof | |
IL120141A (en) | Substituted quinazoline derivatives process for their preparation and pharmaceutical compositions containing them | |
IL117265A (en) | Benzazepine- benzoxazepine- and benzothiazepine-N-acetic acid derivatives their preparation and pharmaceutical compositions containing them | |
ZA989790B (en) | Novel heterocyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them | |
IL117193A0 (en) | Poly-pyrrolecarbox-amidenaphthalenic acid derivatives their preparation and pharmaceutical compositions containing them | |
IL119559A0 (en) | Purin -6- one derivatives their preparation and pharmaceutical compositions containing them | |
IL122705A (en) | 2-(4-Susbstituted)-benzylamino-2-methyl-propanamide derivatives their preparation and pharmaceutical compositions containing them | |
IL117331A0 (en) | Indole derivatives their preparation and pharmaceutical compositions containing them | |
AU661017B2 (en) | N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present | |
IL101453A0 (en) | N-imidazolyl derivatives of substituted indoles,their preparation and pharmaceutical compositions containing them | |
IL114534A (en) | Heterocyclic derivatives of azolones their preparation and pharmaceutical compositions containing them | |
HU896022D0 (en) | Process for the preparation of substituted pyrazoles and pharmaceutical compositions thereof | |
IL106549A0 (en) | Heterocyclic derivatives,their preparation and pharmaceutical compositions containing them |